TRAF6 and myelodysplastic syndrome: In MDS patients, particularly in MDS with deletion of 5q (del(5q)), TRAF6 is overexpressed owing to haploinsufficiency of microRNA-145 and microRNA-146a, negative regulators of TRAF6 (16).